Search clinical trials for: p53 tumor suppressor protein
Total 51560 results
-
C. Babis AndreadisEli Lilly and Company; Genentech, Inc.; Adaptive BiotechnologiesNot yet recruitingMantle Cell LymphomaUnited States
-
Chang Gung Memorial HospitalRecruiting
-
Imperial College LondonNot yet recruiting
-
Shanghai Huaota Biopharmaceutical Co., Ltd.RecruitingCervical Cancer | Advanced Solid TumorChina
-
MedPacto, Inc.Recruiting
-
Li Xiao WeiNot yet recruitingHepatocellular Carcinoma With PVTTChina
-
Sarcoma Alliance for Research through CollaborationDana-Farber Cancer Institute; Cogent Biosciences, Inc.; The Life Raft GroupNot yet recruitingGastrointestinal Stromal Tumors | GISTUnited States
-
Immuneering CorporationRecruitingPancreas Adenocarcinoma | Non-small Cell Lung Cancer | Advanced Solid Tumor (Phase 1) | Malignant Melanoma (Cutaneous)United States
-
Samsung Medical CenterNot yet recruitingThymic Epithelial TumorKorea, Republic of
-
Nanfang Hospital, Southern Medical UniversityRecruiting
-
AstraZenecaRecruitingER+ HER2- Advanced Breast Cancer | High-grade Serous Ovarian Cancer (HGSOC)United States, United Kingdom, Korea, Republic of, Australia, Spain
-
Guangdong Provincial People's HospitalShanghai Institute of Materia Medica, Chinese Academy of SciencesRecruitingCancer | Metastatic Cancer | Malignant Neoplasm | TumorsChina
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingNon Small Cell Lung Cancer | ERBB2 Mutation-Related Tumors | Disitamab Vedotin | ERBB2 Gene Duplication
-
M.D. Anderson Cancer CenterRecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
Stichting European Myeloma NetworkPfizerRecruitingSmoldering Multiple MyelomaNetherlands, France, Italy, Greece, Finland, Norway
-
First Affiliated Hospital of Fujian Medical UniversityRecruitingBiliary Tract MalignanciesChina
-
Nanfang Hospital, Southern Medical UniversityRecruitingBiomarker | RadiosensitivityChina
-
National Cancer Institute (NCI)Not yet recruiting
-
SOTIO Biotech AGRecruitingAdvanced Solid Tumor | Metastatic Solid TumorUnited States, Spain, Czechia, Belgium, France
-
Guangxi Medical UniversityNot yet recruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma | High Grade Serous Adenocarcinoma of OvaryChina
-
Seagen Inc.RemeGen Co., Ltd.RecruitingStomach Neoplasms | Breast Neoplasms | Triple Negative Breast Neoplasms | Gastroesophageal Junction Adenocarcinoma | HER2 Positive Breast Neoplasms | HER2 Low Breast NeoplasmsUnited States, Canada
-
Nanfang Hospital, Southern Medical UniversityRecruiting
-
Centro di Riferimento Oncologico - AvianoRecruiting
-
University of Kansas Medical CenterNational Cancer Institute (NCI); Iovance Biotherapeutics, Inc.RecruitingMetastatic Melanoma | Unresectable Melanoma | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
Bristol-Myers SquibbZai Lab (Shanghai) Co., Ltd.RecruitingCarcinoma, Non-Small-Cell LungJapan, China, Canada, Spain, Germany, Korea, Republic of, Austria, Brazil, Greece, France, United States, Italy, Argentina, Chile, Hungary, India, Turkey, Romania, Netherlands, Poland, Switzerland
-
Istituto Scientifico Romagnolo per lo Studio e...Recruiting
-
National Cancer Institute (NCI)RecruitingMalignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Malignant Female Reproductive System Neoplasm | Recurrent Malignant Female Reproductive System NeoplasmUnited States
-
Guangzhou JOYO Pharma Co., LtdRecruitingLung Neoplasms | Brain Neoplasms | Protein Kinase Inhibitors | Other Protocol Specified CriteriaChina
-
Indapta Therapeutics, INC.RecruitingMultiple Myeloma | Refractory Multiple Myeloma | Refractory Non-Hodgkin Lymphoma | NHL | Blood Cancer | Relapsed Multiple Myeloma | Relapsed Non-Hodgkin LymphomaUnited States
-
Oslo University HospitalUniversity Hospital of North Norway; Helse Stavanger HF; Haukeland University... and other collaboratorsNot yet recruitingRare Malignant Neoplasm
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingPancreatic Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Stage IV Pancreatic Cancer AJCC v8 | Pancreatic Carcinoma | Pancreatic Acinar Cell Carcinoma | Pancreatic Adenosquamous Carcinoma | Pancreatic Squamous Cell CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Comprehensive Cancer Network; Puma Biotechnology, Inc.RecruitingNeratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal CancerGastric Cancer | GastroEsophageal CancerUnited States
-
Hunan Province Tumor HospitalRecruitingNon Small Cell Lung Cancer | EGF-R Positive Non-Small Cell Lung Cancer | RET Gene Mutation | MET AmplificationChina
-
PfizerRecruitingAdvanced or Metastatic Breast CancerUnited States, Taiwan, Canada, Japan, China, Korea, Republic of, Israel, Argentina, Mexico, Australia, Brazil, United Kingdom, India
-
Peking University Cancer Hospital & InstituteRecruitingDigestive System CancersChina
-
Tongji HospitalNot yet recruiting
-
Cancer Institute and Hospital, Chinese Academy...Peking University; Peking University Cancer Hospital & InstituteRecruitingMalignant Tumor | Positron Emission Tomography | Fibroblast Activation Protein InhibitorChina
-
Hunan Province Tumor HospitalXiangya Hospital of Central South UniversityRecruiting
-
Beijing Chest HospitalNational Medical Center for Infectious DiseasesRecruitingPulmonary Tuberculosis | Rifampicin-resistant TuberculosisChina
-
HonorHealth Research InstituteUniversity of Arizona; Agenus Inc.; Translational Genomics Research InstituteNot yet recruitingPancreatic Cancer Metastatic | Pancreatic Adenocarcinoma MetastaticUnited States
-
UK Kidney AssociationRecruitingVasculitis | AL Amyloidosis | Tuberous Sclerosis | Fabry Disease | Cystinuria | Focal Segmental Glomerulosclerosis | IgA Nephropathy | Bartter Syndrome | Pure Red Cell Aplasia | Membranous Nephropathy | Atypical Hemolytic Uremic Syndrome | Autosomal Dominant Polycystic Kidney Disease | Cystinosis | Nephronophthisis | BK Nephropathy and other conditionsUnited Kingdom
-
Hoffmann-La RocheRecruitingEstrogen Receptor-Positive, HER2-Negative Advanced Breast CancerBelgium, Korea, Republic of, United States, Canada, China, Italy, France, Finland, Brazil, Australia, Argentina, Hong Kong, Portugal, Spain, Taiwan, India, Costa Rica, Israel, Thailand, Germany, New Zealand, Poland, Chile, Colombia, Gua... and more
-
Lebanese UniversityHaykel HospitalRecruitingCardiovascular Diseases | Immune System Diseases | Cancer | Breast Cancer | Hepatocellular Carcinoma | Lung Cancer | Chemotherapy | Solid Tumor | Prostate Cancer | Thromboembolism | Colon Cancer | Immunotherapy | Inflammatory DiseasesLebanon
-
Mayo ClinicRecruitingMalignant Solid Neoplasm | Lymphoma | Multiple Myeloma | Hematopoietic and Lymphoid System Neoplasm | Chronic LeukemiaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMantle Cell LymphomaUnited States
-
Hoffmann-La RocheRecruitingRelapsed or Refractory Multiple MyelomaKorea, Republic of, Denmark, Spain, Australia, Italy, New Zealand, France, Canada, Germany
-
iOMEDICO AGRecruitingChronic Lymphocytic Leukemia (CLL) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Marginal Zone Lymphoma (MZL) | Waldenström's Macroglobulinemia (WM)Germany
-
Merck Sharp & Dohme LLCRecruitingSolid Tumor | Endometrial Cancer | Cutaneous Squamous Cell CarcinomaCanada, Taiwan, Italy, Australia, Malaysia, United States, Netherlands, Turkey, France, Germany
-
Fudan UniversityRecruiting
-
Diwakar DavarMerck Sharp & Dohme LLC; Gateway for Cancer ResearchNot yet recruitingPD-1 Refractory Advanced MelanomaUnited States